Literature DB >> 2972425

Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.

M Linker-Israeli1, J D Gray, F P Quismorio, D A Horwitz.   

Abstract

IL-2 production by peripheral blood mononuclear cells (PBM) is decreased in patients with systemic lupus erythematosus (SLE). This defect can be reversed by the removal of CD8+ lymphocytes. The purpose of these studies was to determine whether the CD8+ IL-2 suppressor cells comprise a specific subset or whether all CD8+ cells have this activity. Lymphocyte subsets were identified and separated by two-colour flow cytometry prior to a 48 h mitogen stimulation. The CD8+ cells that suppressed IL-2 production co-expressed HLA DR and were radiosensitive. Other markers co-expressed by CD8+ cells which are found on suppressor cells such as Leu 15 (CD11), Leu 11 (CD16), and Leu 7 were also found on the CD8+ IL-2 suppressor cell population in SLE. In healthy subjects, removal of CD16+, but not of CD8+ cells markedly elevated the production of IL-2. The CD8- CD16+ non-T cell subset suppressed IL-2 production by normal and SLE PBM in autologous and allogeneic combinations. This subset may be a human equivalent of the murine natural suppressor cells. These results demonstrate that the cells that suppress IL-2 production in SLE are heterogeneous, and suggest that they belong to more than one lineage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972425      PMCID: PMC1541602     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  NIH conference. Systemic lupus erythematosus: evolving concepts.

Authors:  J L Decker; A D Steinberg; J L Reinertsen; P H Plotz; J E Balow; J H Klippel
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

3.  Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura.

Authors:  H Mizutani; T Tsubakio; Y Tomiyama; S Katagiri; T Tamaki; Y Kurata; T Yonezawa; S Tarui
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production.

Authors:  M Gullberg; E L Larsson
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.

Authors:  P Katz; A M Zaytoun; J H Lee; R S Panush; S Longley
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.

Authors:  M Goto; K Tanimoto; Y Horiuchi
Journal:  Arthritis Rheum       Date:  1980-11

9.  Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features.

Authors:  J S Smolen; T M Chused; W M Leiserson; J P Reeves; D Alling; A D Steinberg
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

10.  Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Authors:  C Hardt; M Röllinghoff; K Pfizenmaier; H Mosmann; H Wagner
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  4 in total

1.  Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.

Authors:  J Martorell; J Font; I Rojo; R Vilella; M Ingelmo; J Vives
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.

Authors:  G Pantaleo; A De Maria; S Koenig; L Butini; B Moss; M Baseler; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 3.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.

Authors:  Toshio Naito; Hitoshi Ogasawara; Hiroshi Kaneko; Takashi Hishikawa; Iwao Sekigawa; Hiroshi Hashimoto; Naoki Maruyama
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.